{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:11:04Z","timestamp":1793913064921,"version":"4.8.0"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"nsfc","doi-asserted-by":"crossref","award":["82000170"],"award-info":[{"award-number":["82000170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"nsfc","doi-asserted-by":"crossref","award":["81772621"],"award-info":[{"award-number":["81772621"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs. It affects the fates of modified RNAs, including their stability, splicing, and\/or translation, and thus plays important roles in posttranscriptional regulation. To date, m6A methyltransferases have been reported to execute m6A deposition on distinct RNAs by their own or forming different complexes with additional partner proteins. In this review, we summarize the function of these m6A methyltransferases or complexes in regulating the key genes and pathways of cancer biology. We also highlight the progress in the use of m6A methyltransferases in mediating therapy resistance, including chemotherapy, targeted therapy, immunotherapy and radiotherapy. Finally, we discuss the current approaches and clinical potential of m6A methyltransferase-targeting strategies.<\/jats:p>","DOI":"10.1186\/s13045-021-01129-8","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T07:03:11Z","timestamp":1627369391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":264,"title":["N6-methyladenosine methyltransferases: functions, regulation, and clinical potential"],"prefix":"10.1186","volume":"14","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-1993","authenticated-orcid":false,"given":"Yue-Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"issue":"10","key":"1129_CR1","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1129_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","volume":"12","author":"S Ma","year":"2019","unstructured":"Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12(1):121.","journal-title":"J Hematol Oncol"},{"issue":"7544","key":"1129_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","volume":"519","author":"CR Alarcon","year":"2015","unstructured":"Alarcon CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary microRNAs for processing. Nature. 2015;519(7544):482\u20135.","journal-title":"Nature"},{"issue":"5","key":"1129_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton KE, Chen B, Liu K, Hunter OV, Xie Y, Tu BP, et al. The U6 snRNA m(6)A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell. 2017;169(5):824\u201335.","journal-title":"Cell"},{"issue":"8","key":"1129_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SR. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015;12(8):767\u201372.","journal-title":"Nat Methods"},{"issue":"4","key":"1129_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0022-2836(86)90498-5","volume":"189","author":"BE Maden","year":"1986","unstructured":"Maden BE. Identification of the locations of the methyl groups in 18 S ribosomal RNA from Xenopus laevis and man. J Mol Biol. 1986;189(4):681\u201399.","journal-title":"J Mol Biol"},{"issue":"2","key":"1129_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0022-2836(88)90139-8","volume":"201","author":"BE Maden","year":"1988","unstructured":"Maden BE. Locations of methyl groups in 28 S rRNA of Xenopus laevis and man. Clustering in the conserved core of molecule. J Mol Biol. 1988;201(2):289\u2013314.","journal-title":"J Mol Biol"},{"issue":"10","key":"1129_CR8","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","volume":"71","author":"R Desrosiers","year":"1974","unstructured":"Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci. 1974;71(10):3971\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"1129_CR9","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell. 2012;149(7):1635\u201346.","journal-title":"Cell"},{"issue":"7397","key":"1129_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201\u20136.","journal-title":"Nature"},{"issue":"2","key":"1129_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93\u20135.","journal-title":"Nat Chem Biol"},{"issue":"12","key":"1129_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885\u20137.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"1129_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18\u201329.","journal-title":"Mol Cell"},{"issue":"12","key":"1129_CR14","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/cr.2014.152","volume":"24","author":"T Zhu","year":"2014","unstructured":"Zhu T, Roundtree IA, Wang P, Wang X, Wang L, Sun C, et al. Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine. Cell Res. 2014;24(12):1493\u20136.","journal-title":"Cell Res"},{"issue":"3","key":"1129_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N (6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285\u201395.","journal-title":"Nat Cell Biol"},{"key":"1129_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40364-020-00203-6","volume":"8","author":"H Shen","year":"2020","unstructured":"Shen H, Lan Y, Zhao Y, Shi Y, Jin J, Xie W. The emerging roles of N6-methyladenosine RNA methylation in human cancers. Biomark Res. 2020;8:24.","journal-title":"Biomark Res"},{"issue":"5","key":"1129_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"1","key":"1129_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","volume":"8","author":"S Schwartz","year":"2014","unstructured":"Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2019 sites. Cell Rep. 2014;8(1):284\u201396.","journal-title":"Cell Rep"},{"issue":"1","key":"1129_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13(1):117.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"1129_CR20","first-page":"1233","volume":"3","author":"JA Bokar","year":"1997","unstructured":"Bokar JA, Shambaugh ME, Polayes D, Matera AG, Rottman FM. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3(11):1233\u201347.","journal-title":"RNA"},{"issue":"26","key":"1129_CR21","doi-asserted-by":"publisher","first-page":"17697","DOI":"10.1016\/S0021-9258(17)32497-3","volume":"269","author":"JA Bokar","year":"1994","unstructured":"Bokar JA, Rath-Shambaugh ME, Ludwiczak R, Narayan P, Rottman F. Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J Biol Chem. 1994;269(26):17697\u2013704.","journal-title":"J Biol Chem"},{"issue":"7608","key":"1129_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature18298","volume":"534","author":"X Wang","year":"2016","unstructured":"Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 2016;534(7608):575\u20138.","journal-title":"Nature"},{"issue":"2","key":"1129_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63(2):306\u201317.","journal-title":"Mol Cell"},{"issue":"6","key":"1129_CR24","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","volume":"69","author":"J Wen","year":"2018","unstructured":"Wen J, Lv R, Ma H, Shen H, He C, Wang J, et al. Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal. Mol Cell. 2018;69(6):1028\u201338.","journal-title":"Mol Cell"},{"issue":"4","key":"1129_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1261\/rna.064063.117","volume":"24","author":"E Scholler","year":"2018","unstructured":"Scholler E, Weichmann F, Treiber T, Ringle S, Treiber N, Flatley A, et al. Interactions, localization, and phosphorylation of the m (6)A generating METTL3-METTL14-WTAP complex. RNA. 2018;24(4):499\u2013512.","journal-title":"RNA"},{"key":"1129_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","volume":"4","author":"Y Yue","year":"2018","unstructured":"Yue Y, Liu J, Cui X, Cao J, Luo G, Zhang Z, et al. VIRMA mediates preferential m(6)A mRNA methylation in 3\u2019UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 2018;4:10.","journal-title":"Cell Discov"},{"issue":"1","key":"1129_CR27","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/s41467-021-22424-5","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang L, Ren H, Ma L, Guo J, Mao D, et al. Role of Hakai in m(6)A modification pathway in Drosophila. Nat Commun. 2021;12(1):2159.","journal-title":"Nat Commun"},{"issue":"7620","key":"1129_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369\u201373.","journal-title":"Nature"},{"issue":"15","key":"1129_CR29","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1093\/nar\/gkz619","volume":"47","author":"N van Tran","year":"2019","unstructured":"van Tran N, Ernst F, Hawley BR, Zorbas C, Ulryck N, Hackert P, et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res. 2019;47(15):7719\u201333.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1129_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","volume":"15","author":"H Ma","year":"2019","unstructured":"Ma H, Wang X, Cai J, Dai Q, Natchiar SK, Lv R, et al. N (6-) methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Nat Chem Biol. 2019;15(1):88\u201394.","journal-title":"Nat Chem Biol"},{"issue":"11","key":"1129_CR31","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.15252\/embr.201744940","volume":"18","author":"AS Warda","year":"2017","unstructured":"Warda AS, Kretschmer J, Hackert P, Lenz C, Urlaub H, Hobartner C, et al. Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 2017;18(11):2004\u201314.","journal-title":"EMBO Rep"},{"issue":"1","key":"1129_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22\u201335.","journal-title":"Cell"},{"issue":"11","key":"1129_CR33","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23(11):1369\u201376.","journal-title":"Nat Med"},{"issue":"2","key":"1129_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell. 2018;22(2):191\u2013205.","journal-title":"Cell Stem Cell"},{"issue":"19","key":"1129_CR35","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","volume":"38","author":"M Cheng","year":"2019","unstructured":"Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H, Wu M, et al. The m (6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-kappaB\/MYC signaling network. Oncogene. 2019;38(19):3667\u201380.","journal-title":"Oncogene"},{"issue":"12","key":"1129_CR36","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.7150\/jca.42338","volume":"11","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Du Y, Wang L, Liu X. The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation. J Cancer. 2020;11(12):3588\u201395.","journal-title":"J Cancer"},{"key":"1129_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2020.01.033","volume":"20","author":"W Zhao","year":"2020","unstructured":"Zhao W, Cui Y, Liu L, Ma X, Qi X, Wang Y, et al. METTL3 facilitates oral squamous cell carcinoma tumorigenesis by enhancing c-Myc stability via YTHDF1-mediated m (6)A modification. Mol Ther Nucleic Acids. 2020;20:1\u201312.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1129_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fonc.2020.00115","volume":"10","author":"DD Yang","year":"2020","unstructured":"Yang DD, Chen ZH, Yu K, Lu JH, Wu QN, Wang Y, et al. METTL3 promotes the progression of gastric cancer via targeting the MYC pathway. Front Oncol. 2020;10:115.","journal-title":"Front Oncol"},{"issue":"6","key":"1129_CR39","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985\u201399.","journal-title":"Cell"},{"key":"1129_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fonc.2020.00003","volume":"10","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang C, He W, Gou X. Effect of m(6)A RNA methylation regulators on malignant progression and prognosis in renal clear cell carcinoma. Front Oncol. 2020;10:3.","journal-title":"Front Oncol"},{"issue":"1","key":"1129_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12943-019-1119-7","volume":"18","author":"L Liu","year":"2019","unstructured":"Liu L, Wang J, Sun G, Wu Q, Ma J, Zhang X, et al. m(6)A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma. Mol Cancer. 2019;18(1):188.","journal-title":"Mol Cancer"},{"issue":"1","key":"1129_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-020-01281-8","volume":"19","author":"J Xu","year":"2020","unstructured":"Xu J, Wan Z, Tang M, Lin Z, Jiang S, Ji L, et al. N (6)-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating beta-catenin signaling. Mol Cancer. 2020;19(1):163.","journal-title":"Mol Cancer"},{"issue":"5","key":"1129_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41389-020-0229-9","volume":"9","author":"R Zhang","year":"2020","unstructured":"Zhang R, Li SW, Liu L, Yang J, Huang G, Sang Y. TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the beta-catenin\/ABCC9 axis via p62-selective autophagic degradation of Daple. Oncogenesis. 2020;9(5):45.","journal-title":"Oncogenesis"},{"issue":"3","key":"1129_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41422-020-00397-2","volume":"31","author":"F Peng","year":"2021","unstructured":"Peng F, Xu J, Cui B, Liang Q, Zeng S, He B, et al. Oncogenic AURKA-enhanced N(6)-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells. Cell Res. 2021;31(3):345\u201361.","journal-title":"Cell Res"},{"issue":"1","key":"1129_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","volume":"39","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wang T, Wu D, Min Z, Tan J, Yu B. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. J Exp Clin Cancer Res. 2020;39(1):203.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1129_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1129_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","volume":"13","author":"H Chang","year":"2020","unstructured":"Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol. 2020;13(1):159.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"1129_CR48","doi-asserted-by":"publisher","first-page":"e23655","DOI":"10.1002\/jcla.23655","volume":"35","author":"X Liu","year":"2021","unstructured":"Liu X, Xiao M, Zhang L, Li L, Zhu G, Shen E, et al. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K\/AKT\/mTOR signaling pathway. J Clin Lab Anal. 2021;35(3):e23655.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"1129_CR49","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","volume":"160","author":"H Chen","year":"2021","unstructured":"Chen H, Gao S, Liu W, Wong CC, Wu J, Wu J, et al. RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 axis and is a therapeutic target. Gastroenterology. 2021;160(4):1284\u2013300.","journal-title":"Gastroenterology"},{"issue":"8","key":"1129_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41419-020-02847-6","volume":"11","author":"S Chen","year":"2020","unstructured":"Chen S, Li Y, Zhi S, Ding Z, Wang W, Peng Y, et al. WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m(6)A-dependent manner. Cell Death Dis. 2020;11(8):659.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1129_CR51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/hep.31313","volume":"73","author":"GW Kim","year":"2021","unstructured":"Kim GW, Imam H, Khan M, Mir SA, Kim SJ, Yoon SK, et al. HBV-induced increased N6 methyladenosine modification of PTEN RNA affects innate immunity and contributes to HCC. Hepatology. 2021;73(2):533\u201347.","journal-title":"Hepatology"},{"issue":"9","key":"1129_CR52","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1111\/jcmm.16478","volume":"25","author":"X Lai","year":"2021","unstructured":"Lai X, Wei J, Gu XZ, Yao XM, Zhang DS, Li F, et al. Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells. J Cell Mol Med. 2021;25(9):4248\u201359.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"1129_CR53","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41419-020-03049-w","volume":"11","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li S, Yu W, Zhao Z, Gao J, Chen C, et al. N(6)-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN\/TMEM127 and promotes sensitivity to everolimus in gastric cancer. Cell Death Dis. 2020;11(10):836.","journal-title":"Cell Death Dis"},{"issue":"9","key":"1129_CR54","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","volume":"20","author":"J Liu","year":"2018","unstructured":"Liu J, Eckert MA, Harada BT, Liu SM, Lu Z, Yu K, et al. m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol. 2018;20(9):1074\u201383.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1129_CR55","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41467-021-21828-7","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Wang J, Tsui YM, Shi C, Wang Y, Zhang X, et al. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-beta2. Nat Commun. 2021;12(1):1518.","journal-title":"Nat Commun"},{"issue":"1","key":"1129_CR56","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-020-00966-3","volume":"13","author":"DAJ Lopez","year":"2020","unstructured":"Lopez DAJ, Grinan-Lison C, Jimenez G, Marchal JA. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. J Hematol Oncol. 2020;13(1):136.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1129_CR57","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12(1):1394.","journal-title":"Nat Commun"},{"issue":"21","key":"1129_CR58","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.1111\/jcmm.15736","volume":"24","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhang P, Long C, Ma X, Huang H, Kuang X, et al. m(6)A methyltransferase METTL3 promotes retinoblastoma progression via PI3K\/AKT\/mTOR pathway. J Cell Mol Med. 2020;24(21):12368\u201378.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"1129_CR59","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, et al. PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 2020;11(9):797.","journal-title":"Cell Death Dis"},{"issue":"6810","key":"1129_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307\u201310.","journal-title":"Nature"},{"issue":"1","key":"1129_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-017-0410-6","volume":"10","author":"CT Kwok","year":"2017","unstructured":"Kwok CT, Marshall AD, Rasko JE, Wong JJ. Genetic alterations of m(6)A regulators predict poorer survival in acute myeloid leukemia. J Hematol Oncol. 2017;10(1):39.","journal-title":"J Hematol Oncol"},{"key":"1129_CR62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bcp.2018.12.014","volume":"160","author":"MB Uddin","year":"2019","unstructured":"Uddin MB, Roy KR, Hosain SB, Khiste SK, Hill RA, Jois SD, et al. An N(6)-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells. Biochem Pharmacol. 2019;160:134\u201345.","journal-title":"Biochem Pharmacol"},{"key":"1129_CR63","doi-asserted-by":"publisher","first-page":"113908","DOI":"10.1016\/j.envpol.2019.113908","volume":"259","author":"T Zhao","year":"2020","unstructured":"Zhao T, Sun D, Zhao M, Lai Y, Liu Y, Zhang Z. N(6)-methyladenosine mediates arsenite-induced human keratinocyte transformation by suppressing p53 activation. Environ Pollut. 2020;259:113908.","journal-title":"Environ Pollut"},{"issue":"6","key":"1129_CR64","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9(6):400\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1129_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41389-020-00290-y","volume":"10","author":"L Cheng","year":"2021","unstructured":"Cheng L, Zhang X, Huang YZ, Zhu YL, Xu LY, Li Z, et al. Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p\/METTL3\/m(6)A\/p21 pathway. Oncogenesis. 2021;10(1):7.","journal-title":"Oncogenesis"},{"issue":"1","key":"1129_CR66","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-020-01249-8","volume":"19","author":"M Wang","year":"2020","unstructured":"Wang M, Liu J, Zhao Y, He R, Xu X, Guo X, et al. Upregulation of METTL14 mediates the elevation of PERP mRNA N(6) adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020;19(1):130.","journal-title":"Mol Cancer"},{"key":"1129_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1756-8722-6-23","volume":"6","author":"MN Saha","year":"2013","unstructured":"Saha MN, Qiu L, Chang H. Targeting p53 by small molecules in hematological malignancies. J Hematol Oncol. 2013;6:23.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"1129_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrd4236","volume":"13","author":"KH Khoo","year":"2014","unstructured":"Khoo KH, Verma CS, Lane DP. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov. 2014;13(3):217\u201336.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"1129_CR69","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/2159-8290.CD-15-0011","volume":"5","author":"AN Hata","year":"2015","unstructured":"Hata AN, Engelman JA, Faber AC. The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 2015;5(5):475\u201387.","journal-title":"Cancer Discov"},{"key":"1129_CR70","doi-asserted-by":"publisher","first-page":"144076","DOI":"10.1016\/j.gene.2019.144076","volume":"722","author":"H Wang","year":"2020","unstructured":"Wang H, Xu B, Shi J. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Gene. 2020;722:144076.","journal-title":"Gene"},{"issue":"22","key":"1129_CR71","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-18-2868","volume":"79","author":"F Li","year":"2019","unstructured":"Li F, Yi Y, Miao Y, Long W, Long T, Chen S, et al. N(6)-methyladenosine modulates nonsense-mediated mRNA decay in human glioblastoma. Cancer Res. 2019;79(22):5785\u201398.","journal-title":"Cancer Res"},{"issue":"9","key":"1129_CR72","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrc883","volume":"2","author":"S Cory","year":"2002","unstructured":"Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002;2(9):647\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1129_CR73","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7150\/ijbs.20052","volume":"13","author":"M Farhan","year":"2017","unstructured":"Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W. FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci. 2017;13(7):815\u201327.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"1129_CR74","doi-asserted-by":"publisher","first-page":"e103181","DOI":"10.15252\/embj.2019103181","volume":"39","author":"Z Lin","year":"2020","unstructured":"Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X, et al. RNA m(6)A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. EMBO J. 2020;39(12):e103181.","journal-title":"EMBO J"},{"issue":"1","key":"1129_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.stem.2012.12.007","volume":"12","author":"A Sarkar","year":"2013","unstructured":"Sarkar A, Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 2013;12(1):15\u201330.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"1129_CR76","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/onc.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, et al. Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance. Oncogene. 2018;37(4):522\u201333.","journal-title":"Oncogene"},{"key":"1129_CR77","doi-asserted-by":"publisher","first-page":"8849218","DOI":"10.1155\/2020\/8849218","volume":"2020","author":"Q Gao","year":"2020","unstructured":"Gao Q, Zheng J, Ni Z, Sun P, Yang C, Cheng M, et al. The m(6)A methylation-regulated AFF4 promotes self-renewal of bladder cancer stem cells. Stem Cells Int. 2020;2020:8849218.","journal-title":"Stem Cells Int"},{"issue":"1","key":"1129_CR78","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stem.2007.02.001","volume":"1","author":"K Miyamoto","year":"2007","unstructured":"Miyamoto K, Araki KY, Naka K, Arai F, Takubo K, Yamazaki S, et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell. 2007;1(1):101\u201312.","journal-title":"Cell Stem Cell"},{"issue":"5897","key":"1129_CR79","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321(5897):1801\u20136.","journal-title":"Science"},{"issue":"6366","key":"1129_CR80","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1126\/science.aao0409","volume":"358","author":"P Wang","year":"2017","unstructured":"Wang P, Xu J, Wang Y, Cao X. An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism. Science. 2017;358(6366):1051\u20135.","journal-title":"Science"},{"issue":"1","key":"1129_CR81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-020-00909-y","volume":"13","author":"WT Wang","year":"2020","unstructured":"Wang WT, Chen TQ, Zeng ZC, Pan Q, Huang W, Han C, et al. The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia. J Hematol Oncol. 2020;13(1):78.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"1129_CR82","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270\u201388.","journal-title":"Cancer Cell"},{"issue":"3","key":"1129_CR83","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335\u201345.","journal-title":"Mol Cell"},{"issue":"3","key":"1129_CR84","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ncb758","volume":"4","author":"Y Fujita","year":"2002","unstructured":"Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 2002;4(3):222\u201331.","journal-title":"Nat Cell Biol"},{"issue":"38","key":"1129_CR85","doi-asserted-by":"publisher","first-page":"26106","DOI":"10.1074\/jbc.M109.040113","volume":"284","author":"H Uranishi","year":"2009","unstructured":"Uranishi H, Zolotukhin AS, Lindtner S, Warming S, Zhang GM, Bear J, et al. The RNA-binding motif protein 15B (RBM15B\/OTT3) acts as cofactor of the nuclear export receptor NXF1. J Biol Chem. 2009;284(38):26106\u201316.","journal-title":"J Biol Chem"},{"issue":"33","key":"1129_CR86","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1038\/s41388-019-0861-z","volume":"38","author":"JY Qian","year":"2019","unstructured":"Qian JY, Gao J, Sun X, Cao MD, Shi L, Xia TS, et al. KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner. Oncogene. 2019;38(33):6123\u201341.","journal-title":"Oncogene"},{"issue":"10","key":"1129_CR87","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.1002\/jcp.29645","volume":"235","author":"R Miao","year":"2020","unstructured":"Miao R, Dai CC, Mei L, Xu J, Sun SW, Xing YL, et al. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer. J Cell Physiol. 2020;235(10):7420\u201332.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1129_CR88","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-019-0818-2","volume":"12","author":"ZF Lim","year":"2019","unstructured":"Lim ZF, Ma PC. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy. J Hematol Oncol. 2019;12(1):134.","journal-title":"J Hematol Oncol"},{"key":"1129_CR89","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40364-020-00212-5","volume":"8","author":"JY Sun","year":"2020","unstructured":"Sun JY, Zhang D, Wu S, Xu M, Zhou X, Lu XJ, et al. Resistance to PD-1\/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives. Biomark Res. 2020;8:35.","journal-title":"Biomark Res"},{"issue":"5","key":"1129_CR90","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41585-020-0298-8","volume":"17","author":"M Carceles-Cordon","year":"2020","unstructured":"Carceles-Cordon M, Kelly WK, Gomella L, Knudsen KE, Rodriguez-Bravo V, Domingo-Domenech J. Cellular rewiring in lethal prostate cancer: the architect of drug resistance. Nat Rev Urol. 2020;17(5):292\u2013307.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"1129_CR91","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","volume":"21","author":"S Rottenberg","year":"2021","unstructured":"Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nat Rev Cancer. 2021;21(1):37\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"1129_CR92","doi-asserted-by":"publisher","first-page":"11366","DOI":"10.1111\/jcmm.15738","volume":"24","author":"J Wei","year":"2020","unstructured":"Wei J, Yin Y, Zhou J, Chen H, Peng J, Yang J, et al. METTL3 potentiates resistance to cisplatin through m(6) A modification of TFAP2C in seminoma. J Cell Mol Med. 2020;24(19):11366\u201380.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1129_CR93","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41419-019-1585-2","volume":"10","author":"L Zhu","year":"2019","unstructured":"Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D, et al. Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death Dis. 2019;10(6):383.","journal-title":"Cell Death Dis"},{"key":"1129_CR94","doi-asserted-by":"publisher","first-page":"119399","DOI":"10.1016\/j.lfs.2021.119399","volume":"276","author":"Z Song","year":"2021","unstructured":"Song Z, Jia G, Ma P, Cang S. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis. Life Sci. 2021;276:119399.","journal-title":"Life Sci"},{"issue":"1","key":"1129_CR95","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/iub.2410","volume":"73","author":"H Ma","year":"2021","unstructured":"Ma H, Shen L, Yang H, Gong H, Du X, Li J. m6A methyltransferase Wilms\u2019 tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK\/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation. IUBMB Life. 2021;73(1):108\u201317.","journal-title":"IUBMB Life"},{"issue":"1","key":"1129_CR96","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13046-021-01934-6","volume":"40","author":"X Liu","year":"2021","unstructured":"Liu X, Su K, Sun X, Jiang Y, Wang L, Hu C, et al. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt\/beta-catenin pathway. J Exp Clin Cancer Res. 2021;40(1):132.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1129_CR97","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc723","volume":"2","author":"J Mann","year":"2002","unstructured":"Mann J. Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer. 2002;2(2):143\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1129_CR98","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.7150\/thno.40144","volume":"10","author":"Z Chen","year":"2020","unstructured":"Chen Z, Wu L, Zhou J, Lin X, Peng Y, Ge L, et al. N6-methyladenosine-induced ERRgamma triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming. Theranostics. 2020;10(8):3382\u201396.","journal-title":"Theranostics"},{"issue":"1","key":"1129_CR99","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","volume":"31","author":"JV McGowan","year":"2017","unstructured":"McGowan JV, Chung R, Maulik A, Piotrowska I, Walker JM, Yellon DM. Anthracycline chemotherapy and cardiotoxicity. Cardiovasc Drugs Ther. 2017;31(1):63\u201375.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"1129_CR100","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","volume":"53","author":"X Pan","year":"2021","unstructured":"Pan X, Hong X, Li S, Meng P, Xiao F. METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner. Exp Mol Med. 2021;53(1):91\u2013102.","journal-title":"Exp Mol Med"},{"issue":"2","key":"1129_CR101","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrc3185","volume":"12","author":"D Fu","year":"2012","unstructured":"Fu D, Calvo JA, Samson LD. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer. 2012;12(2):104\u201320.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1129_CR102","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molcel.2020.06.017","volume":"79","author":"C Zhang","year":"2020","unstructured":"Zhang C, Chen L, Peng D, Jiang A, He Y, Zeng Y, et al. METTL3 and N6-methyladenosine promote homologous recombination-mediated repair of DSBs by modulating DNA-RNA hybrid accumulation. Mol Cell. 2020;79(3):425\u201342.","journal-title":"Mol Cell"},{"issue":"7646","key":"1129_CR103","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature21671","volume":"543","author":"Y Xiang","year":"2017","unstructured":"Xiang Y, Laurent B, Hsu CH, Nachtergaele S, Lu Z, Sheng W, et al. RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response. Nature. 2017;543(7646):573\u20136.","journal-title":"Nature"},{"issue":"2","key":"1129_CR104","first-page":"621","volume":"52","author":"K Taketo","year":"2018","unstructured":"Taketo K, Konno M, Asai A, Koseki J, Toratani M, Satoh T, et al. The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. Int J Oncol. 2018;52(2):621\u20139.","journal-title":"Int J Oncol"},{"issue":"1","key":"1129_CR105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13045-020-00977-0","volume":"13","author":"L Huang","year":"2020","unstructured":"Huang L, Jiang S, Shi Y. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001\u20132020). J Hematol Oncol. 2020;13(1):143.","journal-title":"J Hematol Oncol"},{"key":"1129_CR106","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40364-020-00196-2","volume":"8","author":"J Yu","year":"2020","unstructured":"Yu J, Jiang P, Sun H, Zhang X, Jiang Z, Li Y, et al. Advances in targeted therapy for acute myeloid leukemia. Biomark Res. 2020;8:17.","journal-title":"Biomark Res"},{"key":"1129_CR107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40364-019-0178-7","volume":"7","author":"D Liu","year":"2019","unstructured":"Liu D. Cancer biomarkers for targeted therapy. Biomark Res. 2019;7:25.","journal-title":"Biomark Res"},{"issue":"14","key":"1129_CR108","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.7150\/ijbs.45886","volume":"16","author":"N Ding","year":"2020","unstructured":"Ding N, You A, Tian W, Gu L, Deng D. Chidamide increases the sensitivity of non-small cell lung cancer to crizotinib by decreasing c-MET mRNA methylation. Int J Biol Sci. 2020;16(14):2595\u2013611.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"1129_CR109","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/gcc.20604","volume":"47","author":"PC Ma","year":"2008","unstructured":"Ma PC, Tretiakova MS, MacKinnon AC, Ramnath N, Johnson C, Dietrich S, et al. Expression and mutational analysis of MET in human solid cancers. Genes Chromosomes Cancer. 2008;47(12):1025\u201337.","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"1129_CR110","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41419-020-03148-8","volume":"11","author":"S Liu","year":"2020","unstructured":"Liu S, Li Q, Li G, Zhang Q, Zhuo L, Han X, et al. The mechanism of m(6)A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by beta-elemene. Cell Death Dis. 2020;11(11):969.","journal-title":"Cell Death Dis"},{"issue":"5","key":"1129_CR111","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/jcmm.16114","volume":"25","author":"F Gao","year":"2021","unstructured":"Gao F, Wang Q, Zhang C, Zhang C, Qu T, Zhang J, et al. RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K\/AKT pathway in lung adenocarcinoma. J Cell Mol Med. 2021;25(5):2418\u201325.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1129_CR112","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41392-020-00299-0","volume":"5","author":"T Zhou","year":"2020","unstructured":"Zhou T, Li S, Xiang D, Liu J, Sun W, Cui X, et al. m6A RNA methylation-mediated HNF3gamma reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance. Signal Transduct Target Ther. 2020;5(1):296.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1129_CR113","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12(1):76.","journal-title":"J Hematol Oncol"},{"issue":"18","key":"1129_CR114","doi-asserted-by":"publisher","first-page":"eabd4742","DOI":"10.1126\/sciadv.abd4742","volume":"7","author":"J Tong","year":"2021","unstructured":"Tong J, Wang X, Liu Y, Ren X, Wang A, Chen Z, et al. Pooled CRISPR screening identifies m(6)A as a positive regulator of macrophage activation. Sci Adv. 2021;7(18):eabd4742.","journal-title":"Sci Adv"},{"issue":"12","key":"1129_CR115","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17(12):887\u2013904.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1129_CR116","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","volume":"10","author":"L Yang","year":"2017","unstructured":"Yang L, Zhang Y. Tumor-associated macrophages: from basic research to clinical application. J Hematol Oncol. 2017;10(1):58.","journal-title":"J Hematol Oncol"},{"issue":"20","key":"1129_CR117","doi-asserted-by":"publisher","first-page":"e104514","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"Wang L, Hui H, Agrawal K, Kang Y, Li N, Tang R, et al. m(6)A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020;39(20):e104514.","journal-title":"EMBO J"},{"issue":"6","key":"1129_CR118","first-page":"1129","volume":"104","author":"G Delaney","year":"2005","unstructured":"Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer-Am Cancer Soc. 2005;104(6):1129\u201337.","journal-title":"Cancer-Am Cancer Soc"},{"issue":"4","key":"1129_CR119","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-021-03558-2","volume":"12","author":"P Wu","year":"2021","unstructured":"Wu P, Fang X, Liu Y, Tang Y, Wang W, Li X, et al. N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell carcinoma through caspase1 pathway. Cell Death Dis. 2021;12(4):298.","journal-title":"Cell Death Dis"},{"issue":"12","key":"1129_CR120","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/d41573-019-00179-5","volume":"18","author":"M Cully","year":"2019","unstructured":"Cully M. Chemical inhibitors make their RNA epigenetic mark. Nat Rev Drug Discov. 2019;18(12):892\u20134.","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"1129_CR121","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1016\/j.celrep.2019.02.100","volume":"26","author":"S Selberg","year":"2019","unstructured":"Selberg S, Blokhina D, Aatonen M, Koivisto P, Siltanen A, Mervaala E, et al. Discovery of small molecules that activate RNA methylation through cooperative binding to the METTL3-14-WTAP complex active site. Cell Rep. 2019;26(13):3762\u201371.","journal-title":"Cell Rep"},{"issue":"3","key":"1129_CR122","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1021\/acschembio.5b00812","volume":"11","author":"J Zhang","year":"2016","unstructured":"Zhang J, Zheng YG. SAM\/SAH analogs as versatile tools for SAM-dependent methyltransferases. ACS Chem Biol. 2016;11(3):583\u201397.","journal-title":"ACS Chem Biol"},{"issue":"8","key":"1129_CR123","doi-asserted-by":"publisher","first-page":"463","DOI":"10.7164\/antibiotics.26.463","volume":"26","author":"RL Hamil","year":"1973","unstructured":"Hamil RL, Hoehn MM. A9145, a new adenine-containing antifungal antibiotic. I. Discovery and isolation. J Antibiot (Tokyo). 1973;26(8):463\u20135.","journal-title":"J Antibiot (Tokyo)"},{"issue":"1","key":"1129_CR124","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1038\/s41467-020-17495-9","volume":"11","author":"P Krafcikova","year":"2020","unstructured":"Krafcikova P, Silhan J, Nencka R, Boura E. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Nat Commun. 2020;11(1):3717.","journal-title":"Nat Commun"},{"issue":"3","key":"1129_CR125","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0006-2952(82)90171-X","volume":"31","author":"HG Williams-Ashman","year":"1982","unstructured":"Williams-Ashman HG, Seidenfeld J, Galletti P. Trends in the biochemical pharmacology of 5\u2019-deoxy-5\u2019-methylthioadenosine. Biochem Pharmacol. 1982;31(3):277\u201388.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"1129_CR126","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/cmdc.202000011","volume":"15","author":"RK Bedi","year":"2020","unstructured":"Bedi RK, Huang D, Eberle SA, Wiedmer L, Sledz P, Caflisch A. Small-molecule inhibitors of METTL3, the major human epitranscriptomic writer. ChemMedChem. 2020;15(9):744\u20138.","journal-title":"ChemMedChem"},{"key":"1129_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100291","author":"V Moroz-Omori Elena","year":"2021","unstructured":"Moroz-Omori Elena V, Danzhi H, Rajiv-Kumar B, Sherry JC, Elena B, Aymeric D, et al. METTL3 inhibitors for epitranscriptomic modulation of cellular processes. ChemMedChem. 2021. https:\/\/doi.org\/10.1002\/cmdc.202100291.","journal-title":"ChemMedChem"},{"issue":"7860","key":"1129_CR128","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593(7860):597\u2013601.","journal-title":"Nature"},{"issue":"5","key":"1129_CR129","first-page":"1375","volume":"43","author":"D Yi","year":"2020","unstructured":"Yi D, Wang R, Shi X, Xu L, Yilihamu Y, Sang J. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6methyladenosine and hsamiR146a5p expression. Oncol Rep. 2020;43(5):1375\u201386.","journal-title":"Oncol Rep"},{"issue":"4","key":"1129_CR130","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","volume":"10","author":"PK Chiang","year":"1996","unstructured":"Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, et al. S-Adenosylmethionine and methylation. FASEB J. 1996;10(4):471\u201380.","journal-title":"FASEB J"},{"issue":"5","key":"1129_CR131","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0955-2863(90)90070-2","volume":"1","author":"JD Finkelstein","year":"1990","unstructured":"Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1(5):228\u201337.","journal-title":"J Nutr Biochem"},{"issue":"6","key":"1129_CR132","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmet.2021.03.024","volume":"33","author":"H Ramalingam","year":"2021","unstructured":"Ramalingam H, Kashyap S, Cobo-Stark P, Flaten A, Chang CM, Hajarnis S, et al. A methionine-Mettl3-N(6)-methyladenosine axis promotes polycystic kidney disease. Cell Metab. 2021;33(6):1234\u201347.","journal-title":"Cell Metab"},{"issue":"6","key":"1129_CR133","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ccell.2020.04.005","volume":"37","author":"M Tajan","year":"2020","unstructured":"Tajan M, Vousden KH. Dietary approaches to cancer therapy. Cancer Cell. 2020;37(6):767\u201385.","journal-title":"Cancer Cell"},{"issue":"6","key":"1129_CR134","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"CH Pui","year":"2012","unstructured":"Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120(6):1165\u201374.","journal-title":"Blood"},{"issue":"1","key":"1129_CR135","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-021-00285-w","volume":"9","author":"F Zheng","year":"2021","unstructured":"Zheng F, Du F, Qian H, Zhao J, Wang X, Yue J, et al. Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer. Biomark Res. 2021;9(1):28.","journal-title":"Biomark Res"},{"key":"1129_CR136","doi-asserted-by":"publisher","first-page":"624395","DOI":"10.3389\/fonc.2021.624395","volume":"11","author":"X Liu","year":"2021","unstructured":"Liu X, Wang P, Teng X, Zhang Z, Song S. Comprehensive analysis of expression regulation for RNA m6A regulators with clinical significance in human cancers. Front Oncol. 2021;11:624395.","journal-title":"Front Oncol"},{"issue":"1","key":"1129_CR137","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-020-00945-8","volume":"13","author":"YM Sun","year":"2020","unstructured":"Sun YM, Chen YQ. Principles and innovative technologies for decrypting noncoding RNAs: from discovery and functional prediction to clinical application. J Hematol Oncol. 2020;13(1):109.","journal-title":"J Hematol Oncol"},{"key":"1129_CR138","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2017.11.018","volume":"415","author":"X Cai","year":"2018","unstructured":"Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang Z, et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. Cancer Lett. 2018;415:11\u20139.","journal-title":"Cancer Lett"},{"issue":"4","key":"1129_CR139","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbrc.2019.07.058","volume":"517","author":"H He","year":"2019","unstructured":"He H, Wu W, Sun Z, Chai L. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m(6)A-caused stabilization of SEC62. Biochem Biophys Res Commun. 2019;517(4):581\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1129_CR140","doi-asserted-by":"publisher","first-page":"e12768","DOI":"10.1111\/cpr.12768","volume":"53","author":"X Cui","year":"2020","unstructured":"Cui X, Wang Z, Li J, Zhu J, Ren Z, Zhang D, et al. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt\/beta-catenin signalling pathway. Cell Prolif. 2020;53(3):e12768.","journal-title":"Cell Prolif"},{"key":"1129_CR141","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2147\/CMAR.S181058","volume":"11","author":"W Wei","year":"2019","unstructured":"Wei W, Huo B, Shi X. miR-600 inhibits lung cancer via downregulating the expression of METTL3. Cancer Manag Res. 2019;11:1177\u201387.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"1129_CR142","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bbrc.2016.11.077","volume":"482","author":"M Du","year":"2017","unstructured":"Du M, Zhang Y, Mao Y, Mou J, Zhao J, Xue Q, et al. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Biochem Biophys Res Commun. 2017;482(4):582\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1129_CR143","doi-asserted-by":"publisher","first-page":"e13298","DOI":"10.1111\/acel.13298","volume":"20","author":"Z Sun","year":"2021","unstructured":"Sun Z, Wang H, Wang Y, Yuan G, Yu X, Jiang H, et al. MiR-103\u20133p targets the m(6)A methyltransferase METTL14 to inhibit osteoblastic bone formation. Aging Cell. 2021;20(2):e13298.","journal-title":"Aging Cell"},{"issue":"1","key":"1129_CR144","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-019-0748-z","volume":"12","author":"WT Wang","year":"2019","unstructured":"Wang WT, Han C, Sun YM, Chen TQ, Chen YQ. Noncoding RNAs in cancer therapy resistance and targeted drug development. J Hematol Oncol. 2019;12(1):55.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"1129_CR145","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.devcel.2021.01.015","volume":"56","author":"X Wang","year":"2021","unstructured":"Wang X, Liu C, Zhang S, Yan H, Zhang L, Jiang A, et al. N(6)-methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles. Dev Cell. 2021;56(5):702\u201315.","journal-title":"Dev Cell"},{"issue":"6","key":"1129_CR146","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157(6):1262\u201378.","journal-title":"Cell"},{"issue":"6213","key":"1129_CR147","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096.","journal-title":"Science"},{"issue":"3","key":"1129_CR148","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cell.2017.04.005","volume":"169","author":"AC Komor","year":"2017","unstructured":"Komor AC, Badran AH, Liu DR. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell. 2017;169(3):559.","journal-title":"Cell"},{"issue":"9","key":"1129_CR149","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41589-019-0327-1","volume":"15","author":"XM Liu","year":"2019","unstructured":"Liu XM, Zhou J, Mao Y, Ji Q, Qian SB. Programmable RNA N(6)-methyladenosine editing by CRISPR-Cas9 conjugates. Nat Chem Biol. 2019;15(9):865\u201371.","journal-title":"Nat Chem Biol"},{"issue":"12","key":"1129_CR150","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/s41587-020-0572-6","volume":"38","author":"C Wilson","year":"2020","unstructured":"Wilson C, Chen PJ, Miao Z, Liu DR. Programmable m(6)A modification of cellular RNAs with a Cas13-directed methyltransferase. Nat Biotechnol. 2020;38(12):1431\u201340.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"1129_CR151","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ymthe.2020.09.028","volume":"29","author":"G Sharma","year":"2021","unstructured":"Sharma G, Sharma AR, Bhattacharya M, Lee SS, Chakraborty C. CRISPR-Cas9: a preclinical and clinical perspective for the treatment of human diseases. Mol Ther. 2021;29(2):571\u201386.","journal-title":"Mol Ther"},{"issue":"12","key":"1129_CR152","doi-asserted-by":"publisher","first-page":"108544","DOI":"10.1016\/j.celrep.2020.108544","volume":"33","author":"B Rong","year":"2020","unstructured":"Rong B, Zhang Q, Wan J, Xing S, Dai R, Li Y, et al. Ribosome 18S m(6)A methyltransferase METTL5 promotes translation initiation and breast cancer cell growth. Cell Rep. 2020;33(12):108544.","journal-title":"Cell Rep"},{"key":"1129_CR153","doi-asserted-by":"publisher","first-page":"617174","DOI":"10.3389\/fgene.2020.617174","volume":"11","author":"S Sun","year":"2020","unstructured":"Sun S, Fei K, Zhang G, Wang J, Yang Y, Guo W, et al. Construction and comprehensive analyses of a METTL5-associated prognostic signature with immune implication in lung adenocarcinomas. Front Genet. 2020;11:617174.","journal-title":"Front Genet"},{"issue":"12","key":"1129_CR154","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1016\/j.cell.2021.03.062","volume":"184","author":"M Mendel","year":"2021","unstructured":"Mendel M, Delaney K, Pandey RR, Chen KM, Wenda JM, Vagbo CB, et al. Splice site m(6)A methylation prevents binding of U2AF35 to inhibit RNA splicing. Cell. 2021;184(12):3125\u201342.","journal-title":"Cell"},{"issue":"9","key":"1129_CR155","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nm.4165","volume":"22","author":"SC Lee","year":"2016","unstructured":"Lee SC, Abdel-Wahab O. Therapeutic targeting of splicing in cancer. Nat Med. 2016;22(9):976\u201386.","journal-title":"Nat Med"},{"issue":"1","key":"1129_CR156","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40364-020-00244-x","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Hu X, Liu J, Wang R, Zhang C, Han F, et al. N6-methyladenine modification in noncoding RNAs and its function in cancer. Biomark Res. 2020;8(1):61.","journal-title":"Biomark Res"},{"issue":"4","key":"1129_CR157","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640\u201350.","journal-title":"Mol Cell"},{"issue":"1","key":"1129_CR158","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-020-00895-1","volume":"13","author":"Q Wang","year":"2020","unstructured":"Wang Q, Geng W, Guo H, Wang Z, Xu K, Chen C, et al. Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer. J Hematol Oncol. 2020;13(1):57.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1129_CR159","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbrc.2020.01.042","volume":"524","author":"S Wanna-Udom","year":"2020","unstructured":"Wanna-Udom S, Terashima M, Lyu H, Ishimura A, Takino T, Sakari M, et al. The m6A methyltransferase METTL3 contributes to transforming growth factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB. Biochem Biophys Res Commun. 2020;524(1):150\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7724","key":"1129_CR160","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-018-0538-8","volume":"561","author":"J Choe","year":"2018","unstructured":"Choe J, Lin S, Zhang W, Liu Q, Wang L, Ramirez-Moya J, et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature. 2018;561(7724):556\u201360.","journal-title":"Nature"},{"issue":"1","key":"1129_CR161","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-020-00924-z","volume":"13","author":"Y He","year":"2020","unstructured":"He Y, Khan S, Huo Z, Lv D, Zhang X, Liu X, et al. Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. J Hematol Oncol. 2020;13(1):103.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"1129_CR162","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H, et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell. 2019;35(4):677\u201391.","journal-title":"Cancer Cell"},{"issue":"1","key":"1129_CR163","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38(1):79\u201396.","journal-title":"Cancer Cell"},{"issue":"1","key":"1129_CR164","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-020-00872-8","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H, Xie W. m(6)A-binding proteins: the emerging crucial performers in epigenetics. J Hematol Oncol. 2020;13(1):35.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1129_CR165","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, et al. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13(1):90.","journal-title":"J Hematol Oncol"},{"key":"1129_CR166","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40364-020-00225-0","volume":"8","author":"C Xue","year":"2020","unstructured":"Xue C, Zhao Y, Li L. Advances in RNA cytosine-5 methylation: detection, regulatory mechanisms, biological functions and links to cancer. Biomark Res. 2020;8:43.","journal-title":"Biomark Res"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-021-01129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-021-01129-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-021-01129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T09:08:52Z","timestamp":1675588132000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-021-01129-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":166,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1186\/s13045-021-01129-8","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"assertion":[{"value":"11 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable for this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}